Devices & Implants (Ophthalmology, Orthopaedic, and Cardiac implants)
Manufacturers of high-tech medical devices such as cardiac implants, orthopaedics, neuromodulation systems, stents and wound-care products
Capturing value in implants
In this sector, growth is strongest in high-innovation niches such as multifocal intra-ocular lenses, cementless orthopaedic implants, and newer generation drug-eluting stents.
We support investors and management teams in evaluating opportunities across devices and implants. Our work spans commercial due diligence, transaction support, and growth strategy. We analyse product pipelines, competitive positioning, and customer adoption trends, and benchmark valuations against recent transactions to test the credibility of business plans.
The UK provides an illustrative case: the MedTech sector generates £27bn in turnover, employs over 130,000 people, and supplies the NHS with more than £10bn of products annually, with implants and surgical equipment representing the largest spend. Yet commercialisation of innovation has often lagged behind global peers.
Our devices & implants leads
Our teams combine scientific expertise with deal experience. We bring rigour to forecasting and valuation, assess regulatory and market access dynamics, and help frame development strategies that appeal to potential partners or acquirers. This ensures that investment cases are built on realistic assumptions and that transactions are structured to capture fair value.
Beyond transactions, we support operational priorities such as target operating model design, performance improvement, and digital and data strategy. By combining strategic clarity with an understanding of scientific and clinical realities, we help biotech firms and their backers make sound decisions in an increasingly competitive market.
News & Insights
